Australia markets close in 1 hour 47 minutes

CVS Health Corporation (CVSH34.SA)

São Paulo - São Paulo Delayed price. Currency in BRL
Add to watchlist
32.00-0.10 (-0.31%)
At close: 11:34AM BRT
Currency in BRL

Valuation measures4

Market cap (intra-day) 405.56B
Enterprise value 774.12B
Trailing P/E 10.46
Forward P/E 8.48
PEG ratio (5-yr expected) 1.54
Price/sales (ttm)0.21
Price/book (mrq)1.01
Enterprise value/revenue 0.40
Enterprise value/EBITDA 8.41

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-2.23%
S&P500 52-week change 323.76%
52-week high 340.43
52-week low 30.00
50-day moving average 332.02
200-day moving average 335.28

Share statistics

Avg vol (3-month) 3424
Avg vol (10-day) 3311
Shares outstanding 512.55B
Implied shares outstanding 612.67B
Float 81.25B
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.95
Forward annual dividend yield 42.98%
Trailing annual dividend rate 32.48
Trailing annual dividend yield 37.73%
5-year average dividend yield 42.52
Payout ratio 436.87%
Dividend date 3N/A
Ex-dividend date 419 Apr 2024
Last split factor 25:1
Last split date 321 Nov 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.04%
Operating margin (ttm)2.13%

Management effectiveness

Return on assets (ttm)3.18%
Return on equity (ttm)10.09%

Income statement

Revenue (ttm)359.66B
Revenue per share (ttm)28.12
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 16.92B
Net income avi to common (ttm)7.32B
Diluted EPS (ttm)3.06
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)13.09B
Total cash per share (mrq)10.43
Total debt (mrq)81.79B
Total debt/equity (mrq)110.31%
Current ratio (mrq)0.81
Book value per share (mrq)59.08

Cash flow statement

Operating cash flow (ttm)10.89B
Levered free cash flow (ttm)8.36B